Cellebrite Di Ltd (CLBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 126,029 | 113,276 | 107,549 | 109,049 | 106,858 |
| Cost of Goods | 20,314 | 17,677 | 17,490 | 17,624 | 15,444 |
| Gross Profit | 105,715 | 95,599 | 90,059 | 91,425 | 91,414 |
| Operating Expenses | 87,039 | 81,859 | 78,281 | 76,322 | 72,413 |
| Operating Income | 18,990 | 14,417 | 12,268 | 15,727 | 19,445 |
| Other Income | 5,298 | 6,374 | 7,060 | 4,170 | -223,982 |
| Pre-tax Income | 24,288 | 20,791 | 19,328 | 19,897 | -204,537 |
| Income Tax | 4,099 | 1,315 | 1,928 | 628 | 2,556 |
| Net Income Continuous | 20,189 | 19,476 | 17,400 | 19,269 | -207,093 |
| Net Income | $20,189 | $19,476 | $17,400 | $19,269 | $-207,093 |
| EPS Basic Total Ops | 0.08 | 0.08 | 0.07 | 0.12 | -0.99 |
| EPS Basic Continuous Ops | 0.08 | 0.08 | 0.07 | 0.12 | -0.99 |
| EPS Diluted Total Ops | 0.08 | 0.08 | 0.07 | 0.12 | -0.99 |
| EPS Diluted Continuous Ops | 0.08 | 0.08 | 0.07 | 0.12 | -0.99 |
| EPS Diluted Before Non-Recurring Items | 0.08 | 0.09 | 0.07 | 0.07 | 0.11 |
| EBITDA(a) | $21,205 | $15,807 | $14,376 | $17,590 | $21,331 |